Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why GLP-1 users stop taking the drug.
Trending
- The biggest winners and losers from this week’s volatile market
- Invesco’s Brain Hartigan talks the Nasdaq-100 turning 40 today
- Small plane crashes in Philadelphia, according to sources
- The top10 winter travel destinations on Gen Z’s bucket list
- Julie Stewart-Binks on a career derailed by alleged sexual assault: ‘What could my life have been?’
- How Trump’s Tariffs Could Affect Americans
- Final Trade: GDX, RSP, META, ACN
- U.S. health agencies scrubbing websites to remove ‘gender ideology’
New study reveals why patients stop taking GLP-1 obesity drugs
